RESEARCH PAPER
Prevalence of depression among HIV-positive patients treated with antiretrovirals at different stage of infection
Submission date: 2017-10-28
Final revision date: 2018-04-09
Acceptance date: 2018-04-11
Publication date: 2018-11-20
HIV & AIDS Review 2018;17(4):243-248
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Depression in human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) is common and can have far-reaching implications in patients receiving antiretroviral therapy (ART). A high prevalence of depression has been reported in people living with HIV/AIDS (PLHA). With the improvement in the management of HIV/AIDS patients, depression is becoming a common medical problem and interferes with ART during HIV infection. This study was conducted with the objectives to determine the prevalence of depression and to study its relationship at different stages of infection (WHO staging) and disease progression.
Material and methods:
About 434 HIV-positive patients on ART from Anti-Retroviral Treatment Center in Aligarh, India were interviewed using pre-tested predefined questionnaire PHQ-9. The data was analyzed using SPSS20 and a p-value of less than 0.05 was considered statistically significant.
Results:
We found that 70/434 (16.1%) ART patients suffered from depression, with 13/434 (3%) suffering from moderate and moderately severe depression. In addition, depression was found to be greater among higher stage of the infection. About 9/70 (12.9%) patients with depression were found to be in WHO stage III or IV as compared to 23/364 (6.3%) of non-depressive patients in same WHO stage. Depression was also significantly related with worsening of disease progression, with the mean improvement in CD4 levels with treatment being only 88.54 ± 94.91 in patients suffering from moderate and moderately severe depression, as compared to 197.31 ± 169.84 in non-depressive patients.
Conclusions:
Depression has a significant relation with a higher stage of infection and disease progression of the HIV-infected respondents. Therefore, screening for depression is essential and should be incorporated in primary patient care.
Depression in human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) is common and can have far-reaching implications in patients receiving antiretroviral therapy (ART). A high prevalence of depression has been reported in people living with HIV/AIDS (PLHA). With the improvement in the management of HIV/AIDS patients, depression is becoming a common medical problem and interferes with ART during HIV infection. This study was conducted with the objectives to determine the prevalence of depression and to study its relationship at different stages of infection (WHO staging) and disease progression.
Material and methods:
About 434 HIV-positive patients on ART from Anti-Retroviral Treatment Center in Aligarh, India were interviewed using pre-tested predefined questionnaire PHQ-9. The data was analyzed using SPSS20 and a p-value of less than 0.05 was considered statistically significant.
Results:
We found that 70/434 (16.1%) ART patients suffered from depression, with 13/434 (3%) suffering from moderate and moderately severe depression. In addition, depression was found to be greater among higher stage of the infection. About 9/70 (12.9%) patients with depression were found to be in WHO stage III or IV as compared to 23/364 (6.3%) of non-depressive patients in same WHO stage. Depression was also significantly related with worsening of disease progression, with the mean improvement in CD4 levels with treatment being only 88.54 ± 94.91 in patients suffering from moderate and moderately severe depression, as compared to 197.31 ± 169.84 in non-depressive patients.
Conclusions:
Depression has a significant relation with a higher stage of infection and disease progression of the HIV-infected respondents. Therefore, screening for depression is essential and should be incorporated in primary patient care.
REFERENCES (31)
1.
Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010. PLoS Med 2013; 10: e1001547.
2.
National Mental Health Survey of India, 2015-2016. Prevalence, Patterns and Outcomes, Supported by Ministry of Health and Family Welfare, Government of India, and Implemented by National institute of Mental Health and Neurosciences (NIMHANS) Bengaluru: In Collaboration with Partner Institutions; 2015-2016 (cited 2017 May 3). Availabe from: http://indianmhs.nimhans.ac.in....
3.
Ciesla JA, Roberts JE. Meta-Analysis of the Relationship Between HIV Infection and Risk for Depressive Disorders. Am J Psychiatry 2001; 158: 725-730.
4.
Kinyanda E, Nakasujja N, Levin J, et al. Major depressive disorder and suicidality in early HIV infection and its association with risk factors and negative outcomes as seen in semi-urban and rural Uganda. J Affect Disord 2017; 212: 117-127.
5.
Taniguchi T, Shacham E, Önen NF, et al. Depression severity is associated with increased risk behaviors and decreased CD4 cell counts. AIDS Care 2014; 26: 1004-1012.
6.
Tsai AC. Reliability and validity of depression assessment among persons with HIV in sub-Saharan Africa: systematic review and meta-analysis. J Acquir Immune Defic Syndr 2014; 66: 503-511.
7.
Das M, Isaakidis P, Van den Bergh R, et al. HIV, multidrug-resistant TB and depressive symptoms: when three conditions collide. Glob Health Action 2014; 7: 24912.
8.
Bhatia MS, Munjal S. Prevalence of depression in people living with HIV/AIDS undergoing ART and factors associated with it. J Clin Diagn Res 2014; 8: WC01-4.
9.
Unnikrishnan B, Jagannath V, Ramapuram JT, et al. Study of Depression and Its Associated Factors among Women Living with HIV/AIDS in Coastal South India. ISRN AIDS 2012; 2012: 684972.
10.
Rai P, Verma BL. A study on depression in people living with HIV/AIDS in South-West part of Uttar Pradesh, India. South East Asia J Public Health 2015; 5: 12-17.
11.
Selvaraj V, Ross MW, Unnikrishnan B, Hegde S. Association of quality of life with major depressive disorder among people with HIV in South India. AIDS Care 2013; 25: 169-172.
12.
Mathers CD, Loncar D. Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Med 2006; 3:e442.
13.
Bing EG, Burnam MA, Longshore D, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 2001; 58: 721-728.
14.
Bhat AG, Babu R, Abhishekh HA. Prevalence of depression among HIV patients on antiretro viral therapy: A study from India. Asian J Psychiatr 2013; 6: 249-250.
15.
Leserman J, Petitto JM, Perkins DO, et al. Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. A 2-year follow-up study. Arch Gen Psychiatry 1997; 54: 279-285.
16.
Page-Shafer K, Delorenze GN, Satariano WA, Winkelstein W. Comorbidity and survival in HIV-infected men in the San Francisco Men’s Health Survey. Ann Epidemiol 1996; 6: 420-430.
17.
Leserman J. Role of Depression, Stress, and Trauma in HIV Disease Progression. Psychosom Med 2008; 70: 539-545.
18.
Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV Epidemiology Research Study. JAMA 2001; 285: 1466-1474.
19.
Rivera-Rivera Y, Vázquez-Santiago FJ, Albino E, et al. Impact of Depression and Inflammation on the Progression of HIV Disease. J Clin Cell Immunol 2016; 7; doi:10.4172/2155-9899.1000423.
20.
US department of Veterans Affairs. Primary care of veterans with HIV: Neurology, psychiatry, and pain; April 2009. Available at: https://www.hiv.va.gov/provide... (Accessed: 20.06.2017).
21.
The Economist. Comparing Indian states and territories with countries: An Indian summary. Available at: http://www.economist.com/conte... (Accessed: 13.05.2017).
22.
National AIDS Control Organization, National Institute of Medical Statistics. Annual report 2016-17; 2017. Available at: http://naco.gov.in/sites/defau... (Accessed: 4.05.2017).
23.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-613.
24.
Kochhar PH, Rajadhyaksha SS, Suvarna VR. Translation and validation of brief patient health questionnaire against DSM IV as a tool to diagnose major depressive disorder in Indian patients. J Postgrad Med 2007; 53: 102-107.
25.
World Health Organization. WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children. World Health Organization, Geneva 2007. Available at: http://www.who.int/hiv/pub/vct... (Accessed: 2.06.2015).
26.
IBM Corp. Released 2011. IBM SPSS Statistics for Windows, Version 20.0. IBM Corp., Armonk.
27.
Epitools Epidemiological Calculators. Available at: http://epitools.ausvet.com.au/... (Accessed: 31.06.2017).
28.
Antelman G, Kaaya S, Wei R, et al. Depressive Symptoms Increase Risk of HIV Disease Progression and Mortality Among Women in Tanzania. J Acquir Immune Defic Syndr 2007; 44: 470-477.
29.
Kaharuza FM, Bunnell R, Moss S, et al. Depression and CD4 Cell Count Among Persons with HIV Infection in Uganda. AIDS Behav 2006; 10: 105-111.
30.
Katz MH, Douglas JM, Bolan GA, et al. Depression and use of mental health services among HIV-infected men. AIDS Care 1996; 8: 433-442.
31.
L’akoa RM, Noubiap JJ, Fang Y, et al. Prevalence and correlates of depressive symptoms in HIV-positive patients: a cross-sectional study among newly diagnosed patients in Yaoundé, Cameroon. BMC Psychiatry 2013; 13: 228.
Share
RELATED ARTICLE
| eISSN: | 1732-2707 |
| ISSN: | 1730-1270 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
